Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07170423 · ClinicalTrials.gov registry record · NA
Automated Text Message Reminders to Promote Hearing Aid Adoption
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT07170423: Clinical Trial NA study, sponsored by Stanford University.
NCT07170423 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 190 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07170423, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
Many individuals with hearing loss do not receive adequate hearing healthcare. Only about 30 percent of people that are found to have hearing loss during a hearing test go on to use hearing aids. The investigators propose to test the use of text message reminders to educate patients with hearing loss, and to encourage them to get hearing aids. The study objective is to examine whether automated text-messaging reminders increase the use of hearing aids among patients with hearing loss, who are hearing aid candidates.
Primary Outcome
Participants will be queried on whether they have obtained hearing aids since enrollment in the study. Participants who have not obtained hearing aids, will be asked to rate the likelihood that they would obtain hearing aids. Likelihood will be assessed on an 11-point visual analogue scale (VAS). Score range: 0 to 10 (0 = not likely, 10 = very likely). Participants who have already obtained hearing aids will be assigned a score of 10.
Interventions
- BEHAVIORAL Automated text message reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2025-11 |
| Est. Completion | 2027-11 |
| Phase | NA |
What is known before NCT07170423 opens enrollment
NCT07170423 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 0 conditions, and to 1 intervention - of which Automated text message reminder is the first listed.
NCT07170423 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07170423 about?
NCT07170423 is a clinical study titled "Automated Text Message Reminders to Promote Hearing Aid Adoption". Many individuals with hearing loss do not receive adequate hearing healthcare. Only about 30 percent of people that are found to have hearing loss during a hearing test go on to use hearing aids. The investigators propose to test the use of text message reminders to educate patients with hearing los...
What is the current status of trial NCT07170423?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2025-11. Estimated completion is 2027-11.
What interventions are being tested in trial NCT07170423?
The interventions under investigation include: Automated text message reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT07170423?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07170423's enrollment target sits among peer trials
190 574th of 2000 higher than 1,425 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia